Lonza Consumer Health, Inc.
Lonza is the preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to prevent illness and enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. These enable our customers to commercialize their discoveries and innovations in the healthcare sector.
Lonza’s industry-leading Capsugel® capsules and encapsulation technologies, formulation know-how and science-backed ingredients combined with our customer-focused services, provide unique and innovative solutions for nutraceutical companies.
Founded in 1897 in the Swiss Alps, today Lonza operates across three continents. With approximately 14,000 full-time employees, we are built from high-performing teams and of individual talent who make a meaningful difference to our own business, as well as to the communities in which we operate. The company generated sales of CHF 4.5 billion in 2020 with a CORE EBITDA of CHF 1.4 billion. Find out more on www.lonza.com
Brands: Carnipure(r)|ResistAid(r)|Aldo(tm)|Polyaldo(tm)|Glycomul(tm)|Glycosperse(tm)|Aldosperse(tm)|Vcaps(r) Plus HPMC|DRcaps(tm)|Vcaps(r)|Plantcaps(r)|Coni-Snap(r)|DUOCAPS(r)|Licaps(R)|OceanCaps(R)